BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 3, 2000
View Archived Issues
Bristol-Myers Squibb and Lexicon team up for high-throughput genetic target validation
Read More
Telik awarded SBIR grant for new TRAP applications
Read More
MGI Pharma commences phase II liver cancer trial with irofulven
Read More
NIH grants anti-Notch-1 monoclonal antibody technology to Viragen
Read More
SangStat receives grant to fund studies of RDP-58 in primate model of HIV infection
Read More
Alkermes completes patient enrollment in clinical trial of new treatment for alcoholism
Read More
Antex Pharma and Lyotropic create joint antibiotic development program
Read More
Pfizer transfers anticancer compound to OSI; early trial results released
Read More
Rigel obtains rights to antiviral drug technologies from Questcor
Read More
Inhaled morphine in phase II for breakthrough pain
Read More
Thymitaq enters phase III for HCC
Read More
First approval for recombinant drug for infertility
Read More
Spanish group presents new CCK1 antagonists with anxiolytic-like effects in Alicante
Read More
Versicor identifies promising leads in new class of antibiotics: inhibitors of peptide deformylase
Read More
New class of oral TNF-alpha synthesis inhibitors presented at September conference
Read More
Dana-Farber reports SAR profile of novel class of antifolates
Read More
Novartis reports success in developing orally active dual MMP/TNF-alpha inhibitors
Read More
Keppra receives E.U. approval for treatment of epilepsy
Read More
Dual D2/beta2-adrenoceptor agonists in clinical development at AstraZeneca for respiratory diseases
Read More
FDA approves Fosamax for use in men with osteoporosis
Read More
Clinical safety and pharmacokinetics of ravuconazole discussed at ICAAC
Read More
Novel polypeptide with potential for diabetes Rx described by ZymoGenetics
Read More
Angiopoietin-related protein isolated at Regeneron
Read More
New benzaldehyde derivatives from Norsk Hydro suppress increased cell proliferation
Read More
Synthesis and use of new Sankyo compounds elevating [Ca2+]i levels described in recent patent
Read More
Anti-H. pylori agents prepared and tested at Welfide
Read More
Mevinolin derivatives for disorders mediated by LFA-1/ICAM-1 interactions
Read More
GGTase-inhibiting antifungal agents identified by Banyu
Read More